297 related articles for article (PubMed ID: 31226168)
1. Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis.
Morgan EL; Macdonald A
PLoS Pathog; 2019 Jun; 15(6):e1007835. PubMed ID: 31226168
[TBL] [Abstract][Full Text] [Related]
2. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
3. Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: abrogation of constitutive monocyte chemoattractant protein-1 production.
Hess S; Smola H; Sandaradura De Silva U; Hadaschik D; Kube D; Baldus SE; Flucke U; Pfister H
J Immunol; 2000 Aug; 165(4):1939-48. PubMed ID: 10925276
[TBL] [Abstract][Full Text] [Related]
4. STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle.
Morgan EL; Wasson CW; Hanson L; Kealy D; Pentland I; McGuire V; Scarpini C; Coleman N; Arthur JSC; Parish JL; Roberts S; Macdonald A
PLoS Pathog; 2018 Apr; 14(4):e1006975. PubMed ID: 29630659
[TBL] [Abstract][Full Text] [Related]
5. The STAT3-miR-223-TGFBR3/HMGCS1 axis modulates the progression of cervical carcinoma.
Zhang J; Jiang M; Qian L; Lin X; Song W; Gao Y; Zhou Y
Mol Oncol; 2020 Sep; 14(9):2313-2331. PubMed ID: 32491253
[TBL] [Abstract][Full Text] [Related]
6. STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes.
Xiang M; Birkbak NJ; Vafaizadeh V; Walker SR; Yeh JE; Liu S; Kroll Y; Boldin M; Taganov K; Groner B; Richardson AL; Frank DA
Sci Signal; 2014 Jan; 7(310):ra11. PubMed ID: 24473196
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.
Shukla S; Shishodia G; Mahata S; Hedau S; Pandey A; Bhambhani S; Batra S; Basir SF; Das BC; Bharti AC
Mol Cancer; 2010 Oct; 9():282. PubMed ID: 20977777
[TBL] [Abstract][Full Text] [Related]
8. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY
Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856
[TBL] [Abstract][Full Text] [Related]
9. Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.
Squarize CH; Castilho RM; Sriuranpong V; Pinto DS; Gutkind JS
Neoplasia; 2006 Sep; 8(9):733-46. PubMed ID: 16984731
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
Miao JW; Liu LJ; Huang J
Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
[TBL] [Abstract][Full Text] [Related]
11. Activated Rac1 regulates the degradation of IκBα and the nuclear translocation of STAT3-NFκB complexes in starved cancer cells.
Kim SJ; Yoon S
Exp Mol Med; 2016 May; 48(5):e231. PubMed ID: 27151455
[TBL] [Abstract][Full Text] [Related]
12.
Suradej B; Sookkhee S; Panyakaew J; Mungkornasawakul P; Wikan N; Smith DR; Potikanond S; Nimlamool W
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470515
[No Abstract] [Full Text] [Related]
13. Rac1 mediates STAT3 activation by autocrine IL-6.
Faruqi TR; Gomez D; Bustelo XR; Bar-Sagi D; Reich NC
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9014-9. PubMed ID: 11470914
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the role of endogenous STAT3 in HPV-positive cervical cancer cells.
Strobel TD; Weber M; Heber N; Holzer A; Hoppe-Seyler K; Hoppe-Seyler F
J Med Virol; 2023 Nov; 95(11):e29230. PubMed ID: 38009614
[TBL] [Abstract][Full Text] [Related]
15. Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis.
Shukla S; Mahata S; Shishodia G; Pandey A; Tyagi A; Vishnoi K; Basir SF; Das BC; Bharti AC
PLoS One; 2013; 8(7):e67849. PubMed ID: 23874455
[TBL] [Abstract][Full Text] [Related]
16. Bazedoxifene, a GP130 Inhibitor, Modulates EMT Signaling and Exhibits Antitumor Effects in HPV-Positive Cervical Cancer.
Kim L; Park SA; Park H; Kim H; Heo TH
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445405
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.
Wei LH; Kuo ML; Chen CA; Cheng WF; Cheng SP; Hsieh FJ; Hsieh CY
Gynecol Oncol; 2001 Jul; 82(1):49-56. PubMed ID: 11426961
[TBL] [Abstract][Full Text] [Related]
18. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
Guleria C; Suri V; Kapoor R; Minz RW; Aggarwal R
Gynecol Oncol; 2019 Oct; 155(1):151-160. PubMed ID: 31375269
[TBL] [Abstract][Full Text] [Related]
20. E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer.
Morgan EL; Scarth JA; Patterson MR; Wasson CW; Hemingway GC; Barba-Moreno D; Macdonald A
Cell Death Differ; 2021 May; 28(5):1669-1687. PubMed ID: 33303976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
